Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study

Jennifer M Burr; Marion K Campbell; Susan E Campbell; Jillian J Francis; Alexandra Greene; Rodolfo Hernández; Debra Hopkins; Sharon K McCann; Luke D Vale; Glaucoma screening Platform Study group

doi:10.1186/1471-2288-11-54

Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study

Jennifer M Burr, Marion K Campbell, Susan E Campbell, Jillian J Francis, Alexandra Greene, Rodolfo Hernández, Debra Hopkins, Sharon K McCann, Luke D Vale, Glaucoma screening Platform Study group

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service.

Original language	English
Pages (from-to)	54
Journal	BMC Medical Research Methodology
Volume	11
DOIs	https://doi.org/10.1186/1471-2288-11-54
Publication status	Published - 2011

Access to Document

10.1186/1471-2288-11-54

Cite this

Burr, J. M., Campbell, M. K., Campbell, S. E., Francis, J. J., Greene, A., Hernández, R., Hopkins, D., McCann, S. K., Vale, L. D., & Glaucoma screening Platform Study group (2011). Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study. BMC Medical Research Methodology, 11, 54. https://doi.org/10.1186/1471-2288-11-54

@article{2c8e3b7fa3a14fed92ecf018cdd99a0c,

title = "Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study",

abstract = "Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service.",

author = "Burr, {Jennifer M} and Campbell, {Marion K} and Campbell, {Susan E} and Francis, {Jillian J} and Alexandra Greene and Rodolfo Hern{\'a}ndez and Debra Hopkins and McCann, {Sharon K} and Vale, {Luke D} and {Glaucoma screening Platform Study group}",

year = "2011",

doi = "10.1186/1471-2288-11-54",

language = "English",

volume = "11",

pages = "54",

journal = "BMC Medical Research Methodology",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Developing the clinical components of a complex intervention for a glaucoma screening trial

T2 - a mixed methods study

AU - Burr, Jennifer M

AU - Campbell, Marion K

AU - Campbell, Susan E

AU - Francis, Jillian J

AU - Greene, Alexandra

AU - Hernández, Rodolfo

AU - Hopkins, Debra

AU - McCann, Sharon K

AU - Vale, Luke D

AU - Glaucoma screening Platform Study group

PY - 2011

Y1 - 2011

N2 - Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service.

AB - Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service.

U2 - 10.1186/1471-2288-11-54

DO - 10.1186/1471-2288-11-54

M3 - Article

C2 - 21510850

VL - 11

SP - 54

JO - BMC Medical Research Methodology

JF - BMC Medical Research Methodology

ER -

Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study

Abstract

Access to Document

Fingerprint

Cite this